Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Personalized prophylaxis.

Collins PW.

Haemophilia. 2012 Jul;18 Suppl 4:131-5. doi: 10.1111/j.1365-2516.2012.02838.x.

PMID:
22726096
2.

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia.

Collins PW, Fischer K, Morfini M, Blanchette VS, Björkman S; International Prophylaxis Study Group Pharmacokinetics Expert Working Group.

Haemophilia. 2011 Jan;17(1):2-10. doi: 10.1111/j.1365-2516.2010.02370.x. Epub 2010 Aug 22. Review.

PMID:
20731726
3.

Optimizing factor prophylaxis for the haemophilia population: where do we stand?

Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R.

Haemophilia. 2004 Oct;10 Suppl 4:97-104. Review.

PMID:
15479380
4.

Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia.

Shapiro AD, Korth-Bradley J, Poon MC.

Haemophilia. 2005 Nov;11(6):571-82. Review.

PMID:
16236106
5.

Role of enhanced half-life factor VIII and IX in the treatment of haemophilia.

Mahdi AJ, Obaji SG, Collins PW.

Br J Haematol. 2015 Jun;169(6):768-76. doi: 10.1111/bjh.13360. Epub 2015 Mar 7. Review.

PMID:
25754016
6.

Considerations in individualizing prophylaxis in patients with haemophilia A.

Valentino LA.

Haemophilia. 2014 Sep;20(5):607-15. doi: 10.1111/hae.12438. Epub 2014 Apr 8. Review.

PMID:
24712891
7.

Prophylaxis in the haemophilia population.

Blanchette VS.

Haemophilia. 2010 Jul;16 Suppl 5:181-8. doi: 10.1111/j.1365-2516.2010.02318.x. Review.

PMID:
20590879
8.

Models of prophylaxis.

Berntorp E, Fischer K, Miners A.

Haemophilia. 2012 Jul;18 Suppl 4:136-40. doi: 10.1111/j.1365-2516.2012.02839.x. Review.

PMID:
22726097
9.

Issues in pediatric haemophilia care.

Giordano P, Franchini M, Lassandro G, Faienza MF, Valente R, Molinari AC.

Ital J Pediatr. 2013 Apr 20;39:24. doi: 10.1186/1824-7288-39-24. Review.

10.

[Prophylaxis in patients with haemophilia complicated by inhibitors].

Paweł Ł.

Pol Merkur Lekarski. 2011 Mar;30(177):211-4. Review. Polish.

PMID:
21545000
11.

Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective.

Björkman S.

Haemophilia. 2003 May;9 Suppl 1:101-8; discussion 109-10. Review.

PMID:
12709045
12.

Importance of pharmacokinetics in the management of hemophilia.

Barnes C.

Pediatr Blood Cancer. 2013;60 Suppl 1:S27-9. doi: 10.1002/pbc.24339. Epub 2012 Oct 25. Review.

PMID:
23109436
13.

Treatment on demand--in vivo dose finding studies.

Escobar MA.

Haemophilia. 2003 Jul;9(4):360-7. Review.

PMID:
12828669
14.

Progress in the treatment of bleeding disorders.

Bergman GE.

Thromb Res. 2011 Jan;127 Suppl 1:S3-5. doi: 10.1016/j.thromres.2010.10.007. Epub 2010 Oct 29. Review.

PMID:
21035836
15.

The current status of prophylactic replacement therapy in children and adults with haemophilia.

Ljung R, Gretenkort Andersson N.

Br J Haematol. 2015 Jun;169(6):777-86. doi: 10.1111/bjh.13365. Epub 2015 Mar 29. Review.

PMID:
25819695
16.

Changing paradigm of prophylaxis with longer acting factor concentrates.

Carcao M.

Haemophilia. 2014 May;20 Suppl 4:99-105. doi: 10.1111/hae.12405. Review.

PMID:
24762284
17.

Current issues in prophylactic therapy for persons with hemophilia.

Dunn AL, Abshire TC.

Acta Haematol. 2006;115(3-4):162-71. Review.

PMID:
16549891
18.

A global view on prophylaxis: possibilities and consequences.

Shapiro AD.

Haemophilia. 2003 May;9 Suppl 1:10-7; discussion 18. Review.

PMID:
12709032
19.

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.

Collins P, Chalmers E, Chowdary P, Keeling D, Mathias M, O'Donnell J, Pasi KJ, Rangarajan S, Thomas A.

Haemophilia. 2016 Jul;22(4):487-98. doi: 10.1111/hae.13013. Epub 2016 Jun 16. Review.

PMID:
27311929
20.

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

Hay CR, Brown S, Collins PW, Keeling DM, Liesner R.

Br J Haematol. 2006 Jun;133(6):591-605. Review.

PMID:
16704433

Supplemental Content

Support Center